US drug regulators reject ecstasy as mental health treatment
Decision a setback for Lykos Therapeutics and psychedelic treatment aimed at 13mn Americans with PTSD
Full Article
US drug regulators reject ecstasy as mental health treatment
FT.com
0 shares
1 views
You might like
Related news coverage
US drug regulators reject ecstasy for mental health treatment
The FDA said there wasn't enough data showing the drugs helped patients and asked for another clinical trial.
BBC News